ADVFN - Advanced Financial Network.
HOME» NYSE » O » OCR Stock Price » OCR Stock News

Omnicare Share News

 Omnicare Inc. Stock Price
OCR Stock Price
 Omnicare Inc. Stock Chart
OCR Stock Chart
 Omnicare Inc. Stock News
OCR Stock News
 Omnicare Inc. Company Information
OCR Company Information
 Omnicare Inc. Stock Trades
OCR Stock Trades

Walgreen Plans Asset Swap With Omnicare; August Sales Up

DOW JONES NEWSWIRES Walgreen Co. (WAG) said same-store sales rose a less-than-expected 2.1% in August, the third-straight monthly increase, as the nation's largest drug store chain also announced it will exchange most of its long-term care pharmacy business for substantially all of Omnicare Inc.'s (OCR) home-infusion operations. The swap comes as Walgreen determined it couldn't be a relevant enough player in the long-term care business "without significant additional investment." Meanwhile, Omnicare continues to build its drug-distribution business in the face of sharply lower second-quarter earnings and a raft of management changes, including the abrupt retirement of its chief executive. Financial terms weren't disclosed. Meanwhile, Walgreen has been remodeling stores to better appeal to customers, seeking ways to fuel front-end sales that had softened during the downturn. Like other drug stores, its pharmacy department has also faced pressure, as consumers cut back on doctor's visits, opt for generic drugs and buy medications in bulk. But the pharmacy had a strong 5.1% increase in prescription volume last month, one-third due to a calendar shift. Half of Walgreen's overall same-store-sales growth was due to calendar impacts. That prescription growth far outpaced a decline reported Thursday by smaller rival Rite Aid Corp. (RAD). By segment, Walgreen's August same-store sales rose 2.9% at the pharmacy and 0.7% at the front end. Generic drug introductions and lower flu incidence reduced the pharmacy figure by 2.9 percentage points. Analysts had forecast overall same-store sales increasing 2.4%, rising 1.4% at the front end and 2.9% in the pharmacy. Meanwhile, sales for the quarter ended Tuesday rose 7.6% to $16.89 billion as same-store sales increased 1.5%. Analysts polled by Thomson Reuters most recently forecast $16.8 billion. Full results are due Sept. 28. As of Tuesday, Walgreen operated 8,053 locations, including 7,563 drug stores, 566 more than a year ago. Shares of Walgreen and Omnicare were inactive premarket. -By Matt Jarzemsky, Dow Jones Newswires; 212-416-2240;

Stock News for Omnicare (OCR)
05/26/201514:24:36Additional Proxy Soliciting Materials (definitive) (defa14a)
05/26/201511:26:00INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of...
05/26/201510:51:00Ryan & Maniskas, LLP Announces Investigation of Omnicare Inc.
05/22/201520:00:00SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into...
05/22/201517:28:30Current Report Filing (8-k)
05/22/201517:26:20Additional Proxy Soliciting Materials (definitive) (defa14a)
05/22/201517:10:19Additional Proxy Soliciting Materials (definitive) (defa14a)
05/22/201510:57:00SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation...
05/22/201510:27:00Finkelstein Thompson LLP Investigates Potentially Unfair Buyout...
05/22/201510:08:00SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders...
05/21/201520:30:46For CVS, Big Bet On Pricey Medicines
05/21/201517:10:00WeissLaw LLP: Omnicare, Inc. Sale Under Legal Investigation
05/21/201516:49:40Additional Proxy Soliciting Materials (definitive) (defa14a)
05/21/201516:45:20Additional Proxy Soliciting Materials (definitive) (defa14a)
05/21/201516:43:07Current Report Filing (8-k)
05/21/201516:39:40Additional Proxy Soliciting Materials (definitive) (defa14a)
05/21/201516:05:43Omnicare Declares Quarterly Cash Dividend
05/21/201514:40:00Robbins Arroyo LLP: Acquisition of Omnicare Inc. (OCR) by CVS...
05/21/201514:09:00Harwood Feffer LLP Announces Investigation of Omnicare, Inc.

Omnicare and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations